Daniel Kim

Daniel Kim is a seasoned executive in regulatory operations with significant experience in the biopharmaceutical industry. Currently serving as Executive Director of Regulatory Operations at Inhibrx, Inc., since July 2023, Daniel has previously held key leadership roles at Heron Therapeutics, Inc. as Executive Director of Regulatory Information and Submission Management and Senior Director of Information & Submission Management from August 2018 to July 2023. Prior to that, Daniel served as Senior Director of Regulatory Operations at Receptos, Inc., and Senior Director of Regulatory Affairs and Operations at Arena Pharmaceuticals. In earlier roles, Daniel worked as Principal at Reg Ops Shop. Daniel holds a Bachelor of Science degree in Biology from UC San Diego.